loading
Überblick Nachrichten Preisverlauf Financials Forum Prognose
Schlusskurs vom Vortag:
$53.32
Offen:
$53.59
24-Stunden-Volumen:
799.33K
Relative Volume:
1.22
Marktkapitalisierung:
$2.57B
Einnahmen:
-
Nettoeinkommen (Verlust:
$-146.66M
KGV:
-20.22
EPS:
-2.7541
Netto-Cashflow:
$-133.21M
1W Leistung:
-2.24%
1M Leistung:
+45.64%
6M Leistung:
+51.06%
1J Leistung:
+4.57%
1-Tages-Spanne:
Value
$53.59
$56.77
1-Wochen-Bereich:
Value
$51.80
$57.63
52-Wochen-Spanne:
Value
$26.20
$63.50

Apogee Therapeutics Inc Stock (APGE) Company Profile

Name
Firmenname
Apogee Therapeutics Inc
Name
Sektor
Healthcare (1146)
Name
Branche
Biotechnology (637)
Name
Telefon
650-394-5230
Name
Adresse
221 CRESCENT ST., WALTHAM
Name
Mitarbeiter
196
Name
Twitter
Name
Nächster Verdiensttermin
Name
Neueste SEC-Einreichungen
Name
APGE's Discussions on Twitter

Vergleichen Sie APGE mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Biotechnology icon
APGE
Apogee Therapeutics Inc
 55.66 3.61B 0 -146.66M -133.21M -2.7541
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
 421.71 108.04B 11.39B 3.64B 3.50B 13.99
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
 481.19 60.75B 2.46B -319.09M -52.09M -2.4669
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
 582.30 61.26B 14.21B 4.46B 3.56B 39.69
Biotechnology icon
ARGX
Argen X Se Adr
 829.26 50.32B 3.06B 1.28B 447.35M 19.67
Biotechnology icon
ONC
Beone Medicines Ltd Adr
 315.94 34.14B 4.56B -176.77M 225.30M -1.7177

Apogee Therapeutics Inc Stock (APGE) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2025-10-21 Eingeleitet Mizuho Outperform
2025-09-25 Eingeleitet RBC Capital Mkts Outperform
2025-07-07 Bestätigt BTIG Research Buy
2025-03-13 Eingeleitet Citigroup Buy
2024-11-25 Eingeleitet Canaccord Genuity Buy
2024-05-10 Eingeleitet BofA Securities Buy
2023-12-20 Eingeleitet BTIG Research Buy
2023-08-08 Eingeleitet Guggenheim Buy
2023-08-08 Eingeleitet Jefferies Buy
2023-08-08 Eingeleitet Stifel Buy
2023-08-08 Eingeleitet TD Cowen Outperform
2023-08-08 Eingeleitet Wedbush Outperform
Alle ansehen

Apogee Therapeutics Inc Aktie (APGE) Neueste Nachrichten

pulisher
09:26 AM

Can volume confirm reversal in Apogee Therapeutics Inc.New Guidance & Low Risk Entry Point Tips - newser.com

09:26 AM
pulisher
09:14 AM

Detecting support and resistance levels for Apogee Therapeutics Inc.Earnings Summary Report & Breakout Confirmation Alerts - newser.com

09:14 AM
pulisher
08:46 AM

Real time scanner hits for Apogee Therapeutics Inc. explainedJuly 2025 Opening Moves & Expert Curated Trade Setups - newser.com

08:46 AM
pulisher
04:21 AM

Using data filters to optimize entry into Apogee Therapeutics Inc.Dividend Hike & Safe Capital Growth Plans - newser.com

04:21 AM
pulisher
02:43 AM

How to integrate Apogee Therapeutics Inc. into portfolio analysis toolsJuly 2025 Patterns & Verified Chart Pattern Trade Signals - newser.com

02:43 AM
pulisher
Oct 26, 2025

Will Apogee Therapeutics Inc. stock split attract more investorsWeekly Stock Recap & Daily Profit Maximizing Tips - newser.com

Oct 26, 2025
pulisher
Oct 25, 2025

What analysts say about Apogee Therapeutics Inc stockMarket Entry Points & AI-Driven Stock Forecast Models - earlytimes.in

Oct 25, 2025
pulisher
Oct 25, 2025

Apogee Therapeutics Raises $323.3 Million in Offering - MSN

Oct 25, 2025

Finanzdaten der Apogee Therapeutics Inc-Aktie (APGE)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading

Ähnlich wie APGE

biotechnology RPRX
$37.26
price down icon 0.01%
biotechnology INCY
$91.77
price up icon 0.45%
biotechnology GMAB
$29.17
price down icon 2.36%
biotechnology BNTX
$105.50
price down icon 0.15%
biotechnology INSM
$163.25
price up icon 2.23%
biotechnology ONC
$315.94
price up icon 1.61%
In Yahoo öffnen | In Google öffnen | In Finviz öffnen | In MarketWatch öffnen | Öffnen Sie in EDGAR | Offen in Reuters
Kapitalisierung:     |  Volumen (24h):